Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Paper
  • Published:

Regulation of monocyte chemoattractant protein 1 (MCP-1) release by explants of human visceral adipose tissue

International Journal of Obesity volume 29, pages 1299–1307 (2005)Cite this article

Abstract

BACKGROUND:

Monocyte chemoattractant protein-1 (MCP-1) is a chemokine involved in monocyte recruitment during inflammation whose plasma level is elevated in obesity.

OBJECTIVE:

The present studies were designed to examine the release of MCP-1 in primary culture by explants of visceral adipose tissue from morbidly obese women.

RESULTS:

Most of the MCP-1 released by adipose tissue explants was derived from the nonfat cells in adipose tissue. The release of MCP-1 by adipose tissue explants was upregulated almost five-fold between 3 and 48 h of incubation. Approximately half of this upregulation was due to the release of endogenous tumor necrosis factor α (TNFα) and IL-1β based on the ability of a combination of a soluble TNFα receptor (etanercept) and a blocking antibody against IL-1β to reduce MCP-1 release. The release of MCP-1 over 48 h was unaffected by insulin or dexamethasone but significantly reduced by the combination of both agents. MCP-1 release was reduced by 60% in the presence of an inhibitor of the nuclear factor κB (NF-κB) pathway. There were no significant effects of inhibitors of p44/42 mitogen-activated protein kinase (ERK), Jun N-terminal kinase (JNK) and p38 mitogen-activated protein kinase (p38 MAPK) pathways on MCP-1 release. However, inhibition of MCP-1 release in the presence of inhibitors of both the p38 MAPK and NF-κB pathways was greater than that seen with only the NF-κB inhibitor.

DISCUSSION:

The present data shows that MCP-1 formation is upregulated over a 48-h incubation of primary explants of visceral adipose tissue. Half of this upregulation is dependent upon endogenous TNFα and Il-1β and involves the p38 MAPK and NF-κB pathways.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5

Similar content being viewed by others

References

  1. Linton MF, Fazio S . inflammation, and atherosclerosis. Int J Obes Relat Metab Disord 2003; 27: 535–540.

    Article  Google Scholar 

  2. Sartipy P, Loskutoff DJ . Monocyte chemoattractant protein 1 in obesity and insulin resistance. Proc Natl Acad Sci USA 2003; 100: 7265–7270.

    Article  CAS  Google Scholar 

  3. Takahashi K, Mizuarai S, Araki H, Mashiko S, Ishihara A, Kanatani A, Itadani H, Kotani H . Adiposity elevates plasma MCP-1 levels leading to the increased CD11b-positive monocytes in mice. J Biol Chem 2003; 47: 46654–46660.

    Article  Google Scholar 

  4. Miller GE, Stetler CA, Carney RM, Freedland KE, Banks WA . Clinical depression and inflammatory risk markers for coronary heart disease. Am J Cardiol 2002; 90: 1279–1283.

    Article  Google Scholar 

  5. Glowinska B, Urban M . Selected cytokines (Il-6, Il-8, Il-10, MCP-1, TNF-α) in children and adolescents with atherosclerosis risk factors: obesity, hypertension, diabetes. Wiad Lek 2003; 56: 109–116.

    PubMed  Google Scholar 

  6. Piemonti L, Calori G, Mercalli A, Lattuada G, Monti P, Garancini MP, Constantino F, Ruotolo G, Luzi L, Perseghin G . Fasting plasma leptin, tumor necrosis factor-α receptor 2, and monocyte chemoattracting protein 1 concentration in a population of glucose-tolerant and glucose-intolerant women. Diabetes Care 2003; 26: 2883–2889.

    Article  CAS  Google Scholar 

  7. Mohanty P, Aljada A, Ghanim H, Hofmeyer D, Tripathy D, Syed T, Al-Haddad W, Dhindsa S, Dandona P . Evidence for a potent anti-inflammatory effect of rosiglitazone. J Endocrinol Metab 2004; 89: 2728–2735.

    Article  CAS  Google Scholar 

  8. Christiansen T, Richelsen B, Bruun JM . Monocyte chemoattractant protein-1 is produced in isolated adipocytes, associated with adiposity and reduced after weight loss in morbid obese subjects. Int J Obes Relat Metab Disord 2005; 29: 146–150.

    Article  CAS  Google Scholar 

  9. Bruun JM, Lihn AS, Pedersen SB, Richelsen B . MCP-1 release is higher in visceral than subcutaneous human adipose tissue. Implication of macrophages resident in the adipose tissue. J Clin Endocrinol Metab 2005; 90: 2282–2289.

    Article  CAS  Google Scholar 

  10. Mazurek T, Zhang L, Zalewski A, Mannion JD, Diehl JT, Arafat H, Sarov-Blat L, O'Brien S, Keiper EA, Johnson AG, Martin J, Goldstein BJ, Shi Y . Human epicardial adipose tissue is a source of inflammatory mediators. Circulation 2003; 108: 2460–2466.

    Article  Google Scholar 

  11. Gerhardt CC, Romero IA, Cancello R, Camoin L, Strosberg AD . Chemokines control fat accumulation and leptin secretion by cultured human adipocytes. Mol Cell Endocrinol 2001; 175: 81–92.

    Article  CAS  Google Scholar 

  12. Fasshauer M, Klein J, Kralisch S, Klier M, Lossner U, Bluher M, Paschke R . Monocyte chemoattractant protein 1 expression is stimulated by growth hormone and interleukin-6 in 3T3-L1 adipocytes. Biochem Biophys Res Commun 2004; 317: 598–604.

    Article  CAS  Google Scholar 

  13. Sekine O, Hishio Y, Egawa K, Nakamura T, Maegawa H, Kashiwagi A . Insulin activates CCAAT/enhancer binding proteins and proinflammatory gene expression through the phosphatidylinositol 3-kinase pathway in vascular smooth muscle cells. J Biol Chem 2002; 277: 36631–36639.

    Article  CAS  Google Scholar 

  14. Dandona P, Aljada A, Mohanty P, Ghanim H, Hamouda W, Assian E, Ahmad S . Insulin inhibits intranuclear nuclear factor κB and stimulates IκB in mononuclear cells in obese subjects: evidence for an anti-inflammatory effect?. J Clin Endocrinol Metab 2001; 86: 3257–3265.

    CAS  PubMed  Google Scholar 

  15. Takebayashi K, Aso Y, Inukai T . Initiation of insulin therapy reduces serum concentrations of high-sensitivity C-reactive protein in patients with type 2 diabetes. Metabolism 2004; 43: 693–699.

    Article  Google Scholar 

  16. Aljada A, Ghanim H, Saadeh R, Dandona P . Insulin inhibits NFκB and MCP-1 expression in human aortic endothelial cells. J Clin Endocrinol Metab 2001; 86: 450–453.

    CAS  PubMed  Google Scholar 

  17. Fain JN, Madan AK, Hiler ML, Cheema P, Bahouth SW . Comparison of the release of adipokines by adipose tissue, adipose tissue matrix and adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans. Endocrinology 2004; 145: 2273–2282.

    Article  CAS  Google Scholar 

  18. Fain JN, Kanu A, Bahouth SW, Cowan Jr GSM, Hiler ML, Leffler CW . Comparison of PGE2, prostacyclin and leptin release by human adipocytes versus explants of adipose tissue in primary culture. Prostagl Leuk Essent Fatty Acids 2002; 67: 467–473.

    Article  CAS  Google Scholar 

  19. Schneider A, Harendza S, Zahner G, Jocks T, Wenzel U, Wolf G, Thaiss F, Helmchen U, Stahl RA . Cyclooxygenase metabolites mediate glomerular monocyte chemoattractant protein-1 formation and monocyte recruitment in experimental glomerulonephritis. Kidney Int 1999; 55: 430–441.

    Article  CAS  Google Scholar 

  20. Tobe M, Isobe Y, Tomizawa H, Nagasaki T, Takahashi H, Fukazawa T, Hayash H . Discovery of quinazolines as a novel structural class of potent inhibitors of NF-κB activation. Bioorg Med Chem 2003; 11: 383–391.

    Article  CAS  Google Scholar 

  21. Bennett BL, Sasaki DT, Murray BW, O'Leary EC, Sakata ST, Xu W, Leisten JC, Motiwala A, Pierce S, Satoh Y, Bhagwat SS, Manning AM, Anderson DW . SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase. Proc Natl Acad Sci USA 2001; 98: 13681–13686.

    Article  CAS  Google Scholar 

  22. Favata MF, Horiuchi KY, Manos EJ, Daulerio AJ, Stradley DA, Feeser WS, Van Dyk DE, Pitts WJ, Earl RA, Hobbs F, Copeland RA, Magolda RL, Scherle PA, Trzaskos JM . Identification of a novel inhibitor of mitogen-activated protein kinase kinase. J Biol Chem 1998; 273: 18623–18632.

    Article  CAS  Google Scholar 

  23. Jackson JR, Bolognese B, Hillegass L, Kassis S, Adams J, Griswold DE, Winkler JD . Pharmacological effects of SB 220025, a selective inhibitor of p38 mitogen-activated protein kinase, in angiogenesis and chronic inflammatory disease models. J Pharmacol Exp Ther 1998; 284: 687–692.

    CAS  PubMed  Google Scholar 

  24. Dean JLE, Brook M, Clark AR, Saklatvala J . P38 mitogen-activated protein kinase regulates cyclooxygenase-2 mRNA stability and transcription in lipopolysaccharide-treated human monocytes. J Biol Chem 1999; 274: 264–269.

    Article  CAS  Google Scholar 

  25. Hoffman E, Dittrich-Breiholz O, Holtmann H, Kracht M . Multiple control of interleukin-8 gene expression. J Leuk Biol 2002; 72: 847–855.

    Google Scholar 

  26. Holtmann H, Winzen R, Holland P, Eickemeier S, Hoffman E, Wallach D, Malinin NL, Cooper JA, Resch K, Kracht M . Induction of interleukin-8 synthesis integrates effects on transcription and mRNA degradation from at least three different cytokine- or stress-activated signal transduction pathways. Mol Cell Biol 1999; 19: 6742–6753.

    Article  CAS  Google Scholar 

  27. Fain JN, Bahouth SW, Madan AK . TNFα release by the nonfat cells of human adipose tissue. Int J Obes Relat Metab Disord 2004; 28: 616–622.

    Article  CAS  Google Scholar 

  28. Xu H, Barnes GT, Yang Q, Tan G, Yang D, Chou CJ, Sole J, Nichols A, Ross JS, Tartaglia LA, Chen H . Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest 2003; 112: 1821–1830.

    Article  CAS  Google Scholar 

  29. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante Jr AW . Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 2003; 112: 1796–1808.

    Article  CAS  Google Scholar 

  30. Riese J, Niedobitek G, Lisner R, Jung A, Hohenberger W, Haupt W . Expression of interleukin-6 and monocyte chemoattractant protein-1 by peritoneal sub-mesothelial cells during abdominal operations. J Pathol 2004; 202: 30–34.

    Article  Google Scholar 

  31. Fain JN, Bahouth SW, Madan AK . Haptoglobin release by human adipose tissue in primary culture. J Lipid Res 2004; 45: 536–542.

    Article  CAS  Google Scholar 

  32. Brach MA, Gruss HJ, Riedel D, Asano Y, De Vos S, Herrmann F . Effect of anti-inflammatory agents on synthesis of MCP-1/JE transcripts by human blood monocytes. Mol Pharmacol 1992; 42: 63–68.

    CAS  PubMed  Google Scholar 

  33. Villiger PM, Terkeltaub R, Lotz M . Monocyte chemoattractant protein-1 (MCP-1) expression in human articular cartilage. Induction by peptide regulatory factors and differential effects of dexamethasone and retinoic acid. J Clin Invest 1992; 90: 488–496.

    Article  CAS  Google Scholar 

  34. Slavin J, Unemori E, Hunt TK, Amento E . Monocyte chemotactic protein-1 (MCP-1) mRNA is down-regulated in human dermal fibroblasts by dexamethasone: differential regulation by TGF-β. Growth Factors 1995; 12: 151–157.

    Article  CAS  Google Scholar 

  35. Zhao B, Stavchansky SA, Bowden RA, Bowman PD . Effect of interleukin-1β and tumor necrosis factor-α on gene expression in human endothelial cells. Am J Physiol Cell Physiol 2003; 284: C1577–C1583.

    Article  CAS  Google Scholar 

  36. Fain JN, Bahouth SW, Madan AK . Involvement of multiple signaling pathways in the post-bariatric induction of IL-6 and IL-8 mRNA and release in human visceral adipose tissue. Biochem Pharmacol 2005; 69: 1315–1327.

    Article  CAS  Google Scholar 

  37. Schwartzman S, Fleischmann R, Morgan Jr GJ . Do anti-TNF agents have equal efficacy in patients with rheumatoid arthritis? Arthritis Res Ther 2004; 6: S3–S11.

    Article  CAS  Google Scholar 

  38. Fleishmann RM . Safety of anakinra, a recombinant interleukin-1 receptor antagonist (r-metHuIL-1ra), in patients with rheumatoid arthritis and comparison to anti-TNF-alpha agents. Clin Exp Rheumatol 2002; 20: S35–S41.

    CAS  PubMed  Google Scholar 

  39. Park JS, Kim YS, Jee YK, Myong NH, Lee KY . Interleukin-8 production in tuberculous pleurisy: role of mesothelial cells stimulated by cytokine network involving tumour necrosis factor-α and interleukin-1β. Scan J Immunol 2003; 57: 463–469.

    Article  CAS  Google Scholar 

  40. Galindo M, Santiago B, Alcami J, Rivero M, Martin-Serrano J, Pablos JL . Hypoxia induces expression of the chemokines monocyte chemoattractant protein-1 (MCP-1) and IL-8 in human dermal fibroblasts. Clin Exp Immunol 2001; 123: 36–41.

    Article  CAS  Google Scholar 

  41. Ivacko J, Szaflarski J, Malinak C, Flory C, Warren JS, Silverstein FS . Hypoxic-ischemic injury induces monocyte chemoattractant protein-1 expression in neonatal rat brain. J Cereb Blood Flow Metab 1997; 17: 759–770.

    Article  CAS  Google Scholar 

  42. Kunz M, Bloss G, Gillitzer R, Gross G, Goebeler M, Rapp UR, Ludwig S . Hypoxia/reoxygenation induction of monocyte chemoattractant protein-1 in melanoma cells: involvement of nuclear factor-κB, stimulatory protein-1 transcription factors and mitogen-activated protein kinase pathways. Biochem J 2002; 366: 299–306.

    Article  CAS  Google Scholar 

  43. Negus RP, Turner L, Burke F, Balkwill FR . Hypoxia down-regulates MCP-1 expression: implications for macrophage distribution in tumors. J Leuk Biol 1998; 63: 758–765.

    Article  CAS  Google Scholar 

  44. Bosco MC, Puppo M, Pastorino S, Mi Z, Melillo G, Massazza S, Rapisarda A, Varesio L . Hypoxia selectively inhibits monocyte chemoattractant protein-1 production by macrophages. J Immunol 2004; 172: 1681–1690.

    Article  CAS  Google Scholar 

  45. Hirani N, Antonicelli F, Strieter RM, Wiesener MS, Ratcliffe PJ, Haslett C, Donnelly SC . The regulation of interleukin-8 by hypoxia in human macrophages—a potential role in pathogenesis of the acute respiratory distress syndrome (ARDS). Mol Med 2001; 7: 685–697.

    Article  CAS  Google Scholar 

  46. Safronova O, Nakahama K, Onodera M, Muneta T, Morita I . Effect of hypoxia on monocyte chemotactic protein-1 (MCP-1) gene expression induced by interleukin-1β in human synovial fibroblasts. Inflamm Res 2003; 52: 480–486.

    Article  CAS  Google Scholar 

  47. Tarzami ST, Cheng R, Miao W, Kitsis RN, Berman JW . Chemokine expression in myocardial ischemia: MIP-2 dependent MCP-1 expression protects cardiomyocytes from cell death. J Mol Cell Cardiol 2002; 34: 209–221.

    Article  CAS  Google Scholar 

  48. Wuyts WA, Vanaudenaerde BM, Dupont LJ, Demedts MG, Verleden GM . Involvement of p38 MAPK, JNK, p42/p44 ERK and NF-κB in IL-1β-induced chemokine release in human airway smooth muscle cells. Respir Med 2003; 97: 811–817.

    Article  Google Scholar 

  49. Guan Z, Buckman SY, Pentland AP, Templeton DJ, Morrison AR . Induction of cyclooxygenase-2 by the activated MEKK1 → SEK1/MKK4 → p38 mitogen-activated protein kinase pathway. J Biol Chem 1998; 273: 12901–12908.

    Article  CAS  Google Scholar 

  50. Guan Z, Buckman SY, Miller BW, Springer LD, Morrison AR . Interleukin-1β-induced cyclooxygenase-2 expression requires activation of both c-Jun NH2-terminal kinase and p38 MAPK signal pathways in rat renal mesangial cells. J Biol Chem 1998; 273: 28670–28676.

    Article  CAS  Google Scholar 

  51. Singer CA, Baker KJ, McCaffrey A, AuCoin DP, Dechert MA, Gerthoffer WT . p38 MAPK and NF-κB mediate COX-2 expression in human airway myocytes. Am J Physiol Lung Cell Mol Physiol 2003; 185: L1087–L1098.

    Article  Google Scholar 

  52. Baeuerle PA . IκB-NF-κB structures: at the interface of inflammation control. Cell 1998; 95: 729–731.

    Article  CAS  Google Scholar 

  53. Ritchie MH, Fillmore RA, Lausch RN, Oakes JE . A role for NF-κB binding motifs in the differential induction of chemokine gene expression in human corneal epithelial cells. Invest Ophthalmol Vis Sci 2004; 45: 2299–2305.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Molecular Sciences, College of Medicine, University of Tennessee Health Science Center, Memphis, TN, USA

    J N Fain

  2. Department of Surgery, College of Medicine, University of Tennessee Health Science Center, Memphis, TN, USA

    A K Madan

Authors
  1. J N Fain
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A K Madan
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to J N Fain.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Fain, J., Madan, A. Regulation of monocyte chemoattractant protein 1 (MCP-1) release by explants of human visceral adipose tissue. Int J Obes 29, 1299–1307 (2005). https://doi.org/10.1038/sj.ijo.0803032

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.ijo.0803032

Keywords

This article is cited by

Search

Advanced search

Quick links